The 5 Why's of Injectable Medication Shortages

Recorded On: 03/28/2018

Medication shortages, especially injectable drugs, cause significant risks to patients from both safety and clinical treatment aspects. Clinicians are faced with daily drug shortages in practice settings that necessitate restrictions, rationing, and sometimes rapid changes in therapies. This webinar will explain why drug shortages occur, identify the key stakeholders in drug shortage management, describe the current drug shortages, and offer predictions on how long current injectable medication shortages may last. Dr. Pasko will also discuss the impact to patient care as a result of these shortages and provide strategies for best practices.

Learning Outcome:

At the end of the presentation, attendees will be able to identify the impact of injectable medication shortages on patient care and learn strategies for best practices.

Deborah A. Pasko, PharmD, MHA, BPharm

Director Medication and Safety ASHP

Deborah Pasko, PharmD, MHA, BPharm, is the director of medication safety and quality at the American Society of Health-System Pharmacists. She earned a BPharm from Ohio Northern University, an MHA from Walden University and a PharmD from Idaho State University. She has training and experience in a number of pharmacy practices, including pediatrics, critical care, medication safety, and process improvement. In 2009, she transitioned to hospital administration at the University of Michigan, where she chaired the Pediatric Medication Safety committee and advised the adult committee until2014. She has led pediatric and adult initiatives focused on adverse drug events (ADE) and health care-acquired infection prevention, in addition to serving as lead pharmacist for safety technology implementations, including smart infusion devices and Epic EHR. Dr. Pasko’s professional interests include intravenous and oral liquid standardization, all pillars of the national ADE action plan, antimicrobial resistance and stewardship, opioid stewardship, safety technology solutions, drug shortages and population health initiatives.

CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

Contact Hours: This session has been approved for 1 contact hour

Expiration date for receipt of contact hours: March 28, 2021


Live event: 03/28/2018 at 1:00 PM (EDT) You must register to access.
Webinar Evaluation
Printable Certificate You must register to access.